Latest News about JNJ
Recent news which mentions JNJ
   3 Dow Stocks You Can Confidently Buy Now and Hold Forever
   
  
  
  February 13, 2024
  From Motley Fool
 
   Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?
   
  
  
  February 12, 2024
  From Motley Fool
 
   Passive Income Powerhouses: 7 Blue-Chip Stocks to Own Now
   
  
  
  February 12, 2024
  From InvestorPlace
 
   DNA Sequencing Kit Provider Illumina's Q4 Earnings Edge Above Street Estimates, Works To Resolve GRAIL Quickly
   
  
  
  February 09, 2024
  From Benzinga
 
   Dividend Dynasties: 3 Stocks Set to Deliver Consistent Income
   
  
  
  February 09, 2024
  From InvestorPlace
 
   Bernie Sanders Blasts Big Pharma's Pricing Of Lifesaving Drugs In US During Senate Hearing On Medicare
   
  
  
  February 09, 2024
  From Benzinga
 
   3 Dividend Stocks to Cling to This Year
   
  
  
  February 09, 2024
  From InvestorPlace
 
   The Watch List: Is Warren Buffett Still Selling These 3 Stocks?
   
  
  
  February 08, 2024
  From InvestorPlace
 
   Is Johnson & Johnson a Good Dividend Stock to Buy Now?
   
  February 08, 2024
  Tickers 
   JNJ
  
  
  From Motley Fool
 
   7 Dividend Stocks Worth Holding for the Long Haul
   
  
  
  February 06, 2024
  From InvestorPlace
 
   The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024
   
  
  
  February 06, 2024
  From InvestorPlace
 
   New Hope For Patients With Chronic Autoimmune Conditions: Johnson & Johnson's Investigational Drug Meets Primary Goal In Two Studies
   
  
  
  February 05, 2024
  From Benzinga
 
   2 Healthcare Dividend Kings to Buy and Hold Forever
   
  
  
  February 04, 2024
  From Motley Fool
 
   7 Dividend Stocks That Pay Me More Than $500 Per Month
   
  
  
  February 03, 2024
  From Motley Fool
 
   Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
   
  
  
  February 02, 2024
  From Benzinga
 
   FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000
   
  
  
  January 31, 2024
  From Benzinga
 
   The 7 Best Blue-Chip Stocks to Invest In for Big Gains in 2024
   
  
  
  January 31, 2024
  From InvestorPlace
 
   Buy Alert: 3 Healthcare Stocks Sitting in the Sweet Spot
   
  
  
  January 30, 2024
  From InvestorPlace
 
   Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
   
  
  
  January 30, 2024
  From Benzinga
 
   Will Novo Nordisk Be a $1 Trillion Company by 2030?
   
  
  
  January 30, 2024
  From Motley Fool
 
   Wall Street's Greatest Dividend Stock Just Made History Again, and 99% of Investors Probably Don't Realize It Exists
   
  
  
  January 30, 2024
  From Motley Fool
 From Motley Fool
 
   Hedge Fund Favorites: 7 Stocks the Big Money Is Loving Now
   
  
  
  January 29, 2024
  From InvestorPlace
 
   Johnson & Johnson To Pay $149M In Opioid Settlement, Washington State AG Says 'We Are Not Done'
   
  
  
  January 29, 2024
  From Benzinga
 
   Better Growth Stock: UnitedHealth Group vs. Johnson & Johnson
   
  
  
  January 27, 2024
  From Motley Fool
 
   Should You Buy the Dogs of the Dow in 2024?
   
  
  
  January 27, 2024
  From Motley Fool
 
   Dividend Dynamos- 7 Stocks Delivering Consistent Cash Flow This Year
   
  
  
  January 26, 2024
  From InvestorPlace
 
   Better Dividend Stock to Buy Now: Johnson & Johnson vs. Verizon
   
  
  
  January 25, 2024
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.